Search Results
18 results found for "maryland"
- PDAB Chicanery - How Drug Affordability Boards Are Undermining Public Engagement
Maryland PDAB: How to Follow the Letter of the Law While Breaking Its Spirit Maryland's Prescription On March 18, 2025, the Maryland PDAB posted a revised agenda for their upcoming March 24 meeting. The Maryland PDAB's approach creates a veneer of public engagement while practically guaranteeing that The Maryland case isn't an anomaly. From Maryland's last-minute document dumps to Colorado's refusal to conduct impact analyses and Oregon's
- The Quiet Reconstruction of HCV Treatment Restrictions
This quarter’s research revealed that Missouri and Maryland have reintroduced fibrosis-scoring requirements state Medicaid programs that now have fibrosis staging as a requirement for HCV treatment approval: Maryland
- Prescription Drug Advisory Boards: Who is Impacted and How to get Involved
enacting PDAB legislation: Washington, Oregon, Colorado, Michigan, Minnesota, New Jersey, New Hampshire, Maryland have the ability to enact binding upper payment limit (UPL) settings: Washington, Oregon, Colorado, Maryland
- Prescription Drug Affordability Boards and the ADA
on the total number of drugs on each state's "Eligible for Review" list (or "Selected for Review" in Maryland's In Maryland and Oregon, every drug eligible for review falls into these categories. Maryland's PDAB focuses on endocrine disorders, autoimmune disorders, and respiratory disorders.
- A Patient's Guide to 340B: Why the Decline in Charity Care Matters to You
massive coalition of 60 entities, including a nurses’ union, and startling data supporting the need for Maryland While Maryland already had certain patient protections from these predatory practices on the books, too
- Criminal Counterfeits Threaten Patient Safety
the medicines at a discount to other co-conspirators running distribution companies in Mississippi, Maryland
- The Future of Prescription Drug Affordability Boards and Upper Payment Limits Is Cloudy
In spite of this, Colorado and Maryland, two states that have set UPLs, did not engage in any interdepartmental
- September Shutdown Could Cripple Open Enrollment as HIV Patients Face Coverage Crisis
In Maryland, carriers requested 17.1% increases, but rates would drop to 7.9% if Congress extends enhanced
- The Coming HIV Care Crisis
massive overcharges: Ohio lost $224.8 million in one year, Pennsylvania $605 million over four years, and Maryland
- The Cure Hepatitis C Act of 2026 Bets on a National Drug Contract. The Design Could Narrow Access.
prerequisites, yet some are rebuilding barriers through step therapy and non-preferred drug status, as Maryland
- Policy Failures, Not Fate: Inside 2025's Health-Care Unraveling
Colorado and Maryland, the two states furthest along in setting Upper Payment Limits (UPLs), are basing
- HIV/HCV Co-Infection Watch Q3: July 2026
return of fibrosis staging as a condition of treatment in seven state Medicaid programs — Missouri, Maryland Maryland — new clinical criteria issued May 2026, replacing the January 7, 2021 edition. Maryland imposes no step therapy, no sobriety rule, and no specialty restriction — staging is its only
